ASX Penny Stocks: Brisbane Broncos And 2 More With Growth Potential

The ASX is set for a modestly firmer open today, buoyed by a positive lead from Wall Street's tech sector, although local investors remain cautious amid potential interest rate hikes and upcoming employment data. For those exploring opportunities in smaller or newer companies, penny stocks—despite their somewhat outdated moniker—can still present intriguing possibilities. This article will explore three such stocks that combine financial strength with growth potential, offering investors the chance to uncover hidden value in quality companies.

We're going to check out a few of the best picks from our screener tool.

Brisbane Broncos (ASX:BBL)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Brisbane Broncos Limited, along with its subsidiaries, manages and operates the Brisbane Broncos Rugby League Football teams in Australia, with a market cap of A$168.14 million.

Operations: The company generates revenue primarily from its Sports Management and Entertainment segment, amounting to A$84.94 million.

Market Cap: A$168.14M

Brisbane Broncos Limited, with a market cap of A$168.14 million, has shown strong financial performance. The company reported significant revenue growth to A$59.72 million for the half year ended June 30, 2026, up from A$49.62 million the previous year. Earnings grew by 31% over the past year, outpacing both its five-year average and industry growth rates. With no debt and short-term assets exceeding liabilities, financial stability is evident. While trading below estimated fair value by 37.9%, its Return on Equity remains low at 16.7%. The management team and board are experienced with stable weekly volatility at 9%.

• Click here and access our complete financial health analysis report to understand the dynamics of Brisbane Broncos.
• Assess Brisbane Broncos' previous results with our detailed historical performance reports.

Carnegie Clean Energy (ASX:CCE)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Carnegie Clean Energy Limited focuses on developing the CETO Wave Energy Technology in Australia and has a market cap of A$87.60 million.

Operations: The company generates revenue from its Electronic Components & Parts segment, amounting to A$0.45 million.

Market Cap: A$87.6M

Carnegie Clean Energy Limited, with a market cap of A$87.60 million, remains pre-revenue as it focuses on developing its CETO Wave Energy Technology. Recent financial results indicate a net loss of A$2.77 million for the year ended June 30, 2026, with revenue at A$0.61 million. Despite having short-term assets of A$1.8 million that do not cover its liabilities of A$4.2 million, the company maintains a satisfactory net debt to equity ratio of 8.4%. The auditor has expressed doubts about its ability to continue as a going concern following recent equity offerings totaling A$2.5 million.

• Click here to discover the nuances of Carnegie Clean Energy with our detailed analytical financial health report.
• Review our historical performance report to gain insights into Carnegie Clean Energy's track record.

Turaco Gold (ASX:TCG)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Turaco Gold Limited is a gold exploration and development company operating in Cote d’Ivoire with a market cap of A$933.52 million.

Operations: Turaco Gold Limited currently does not report any revenue segments.

Market Cap: A$933.52M

Turaco Gold Limited, with a market cap of A$933.52 million, is pre-revenue and currently unprofitable, reporting a net loss of A$18.67 million for the half year ended June 30, 2026. The company benefits from stable weekly volatility and has not experienced meaningful shareholder dilution over the past year. Despite having short-term assets of A$55.5 million exceeding liabilities of A$3.4 million, it faces challenges with less than a year's cash runway if its free cash flow continues to decline at historical rates. Recent board changes bring extensive industry experience which may aid future strategic direction in Cote d’Ivoire operations.

• Jump into the full analysis health report here for a deeper understanding of Turaco Gold.
• Assess Turaco Gold's future earnings estimates with our detailed growth reports.

Seize The Opportunity

• Investigate our full lineup of 396 ASX Penny Stocks right here.
• Want To Explore Some Alternatives? AI is about to change healthcare. These 133 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com